Page last updated: 2024-08-16

ribavirin and Hepatitis, Chronic

ribavirin has been researched along with Hepatitis, Chronic in 61 studies

Research

Studies (61)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (1.64)	18.7374
1990's	12 (19.67)	18.2507
2000's	8 (13.11)	29.6817
2010's	34 (55.74)	24.3611
2020's	6 (9.84)	2.80

Authors

Authors	Studies
Abravanel, F; Del Bello, A; Izopet, J; Kamar, N; Pan, Q	1
Liu, HY; Zhao, JM	1
Forgan-Smith, KR; Macdonald, G	1
Biedermann, P; Bock, CT; Choi, M; Hanitsch, LG; Hofmann, J; Mueller, T; Schulz, M; Tacke, F	1
Casper, M; Grünhage, F; Lammert, F; Reichert, MC; Rissland, J	1
Allaire, M; Dao, T; Lebedel, L; Lecouf, A; Lier, C; Nguyen, TTN; Ollivier-Hourmand, I	1
Aslan, AT; Balaban, HY	1
Akhavan, S; Calin, R; Demeret, S; Jaspard, M; Katlama, C; Mallet, V; Peytavin, G; Pourcher, V; Poynard, T; Roque-Afonso, AM; Thibault, V; Todesco, E	1
Gorard, D; Rait, S; Shahid, S; Sharples, E	1
Abravanel, F; Barragué, H; Champagne, E; Condat, B; Izopet, J; Petitdidier, N; Renou, C	1
Chan, JFW; Huang, C; Hung, IFN; Lau, SKP; Sridhar, S; Tang, SCW; Teng, JLL; Woo, PCY; Yap, DYH; Yip, CCY; Yuen, KY	1
Aggarwal, R; Dalton, HR; Izopet, J; Kamar, N; Labrique, A; Pavio, N; Wedemeyer, H	1
Douthwaite, S; Evans, TJ; Hilton, R	1
Chen, G; Pan, Q; Wang, Y; Zhao, J	1
Meister, TL; Steinmann, E; Todt, D	1
Abravanel, F; Izopet, J; Kamar, N; Lhomme, S; Marion, O	1
Aitken, C; Alric, L; Ayuk, F; Bettinger, D; Binder, M; Cornelissen, JJ; de Man, RA; Giordani, MT; Lohse, AW; Mallet, V; Pischke, S; Schlabe, S; Schnitzler, P; Spengler, U; Thimme, R; von Felden, J; Xhaard, A	1
Abravanel, F; Cotler, SJ; Dahari, H; DebRoy, S; Dimeglio, C; Izopet, J; Kamar, N; Lhomme, S; Marion, O; Metsu, D	1
Basho, K; Fahrner, A; Neumann-Haefelin, C; Panning, M	1
Colson, P; Gérolami, R; Hajji, H; Moreau, J; Solas, C	1
Barreiro, P; Camacho, A; Caruz, A; Macías, J; Mira, JA; Neukam, K; Pineda, JA; Rivero, A; Rivero-Juárez, A; Soriano, V	1
Avellón, A; Barreiro, P; Cifuentes, C; Echevarría, JM; Macías, J; Martín-Carbonero, L; Neukam, K; Pineda, JA; Soriano, V; Vargas, J	1
Parvez, MK	1
Chen, K; Debing, Y; Janssen, HL; Metselaar, HJ; Neyts, J; Pan, Q; Peppelenbosch, MP; Van Der Laan, LJ; Wang, Y; Zhou, X	1
Bahra, M; Hofmann, J; Klein, F; Neuhaus, P; Neuhaus, R; Rudolph, B	1
Bremer, B; Dallmeier, K; Debing, Y; Gisa, A; Manns, M; Neyts, J; Pischke, S; Suneetha, PV; Wedemeyer, H	1
Dienes, HP; Galante, A; Gisa, A; Hiller, J; Lohse, AW; Luetgehethmann, M; Nashan, B; Pischke, S; Polywka, S; Sterneck, M; Suneetha, PV	1
Abravanel, F; Alric, L; Beyne-Rauzy, O; Faguer, S; Gaudin, C; Huguet, F; Huynh, A; Kamar, N; Oberic, L; Peron, JM; Recher, C; Roussel, M; Tavitian, S; Ysebaert, L	1
Ho, CM; Hu, RH; Lee, PH; Sun, HY; Tsai, JH; Wu, CH	1
Acosta Materan, R; Martín Arribas, MI; Mora Soler, AM; Pérez Corte, D; Revilla Morato, C; Rodríguez Pérez, A; Velasco-Guardado, A	1
Almeida-Santos, M; Barroso, E; Carmo, J; Curran, M; Marques, S; Mateus, É; Morbey, A; Veloso, J	1
Gouttenoire, J; Moradpour, D; Szkolnicka, D	1
Abravanel, F; Alric, L; Izopet, J; Kamar, N; Lhomme, S; Marion, O; Peron, JM	1
Kater, AP; Schinkel, J; van der Valk, M; Zaaijer, HL	1
Behrendt, P; Brown, RJ; Dammermann, W; Drave, S; Iking-Konert, C; Lüth, S; Pischke, S; Schnoor, U; Steinmann, E; Todt, D; Wedemeyer, H	1
Ledeboer, M; Martens, HA; van Bijnen, ST	1
Zapata, R	1
Gonzalez, SA; Keeffe, EB	1
Fuchs, D; Schloegl, A; Schroecksnadel, S; Vogel, W; Zoller, H	1
Beuers, U; de Niet, A; Reesink, HW; ten Berge, I; Weegink, CJ; Zaaijer, HL	1
Hierro Llanillo, L	1
Hegenbarth, K; Ille, R; Krause, R; Lahousen, T; Lipp, RW; Little, RR; Schnedl, WJ	1
Berg, T; Bergk, A	1
Dalmi, L; Gervain, J; Hunyady, B; Ibrányi, E; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I	1
Berberat, PO; Encke, J; Gotthardt, D; Mehrabi, A; Merle, U; Riediger, C; Sauer, P; Stremmel, W; Weiss, KH	1
Paltsev, AI	1
Ferenci, P; Staufer, K	1
Conte, PE; Ferrara, S; Mangano, A; Scotto, G; Tantimonaco, G	1
Bonino, F; Costa, C; Cozzolongo, R; Craxi, A; Di Marco, V; Fabiano, A; Garripoli, A; Rizzetto, M; Smedile, A; Verme, G	1
Braconier, JH; Engman, K; Paulsen, O; Widell, A	1
Benhamou, JP; Boyer, N; Castelnau, C; Erlinger, S; Marcellin, P; Martinot, M; Pouteau, M	1
Bailly, F; Berby, F; Berthillon, P; Habersetzer, F; Pichoud, C; Trepo, C; Vitvitski, L	1
Erhard, A; Häussinger, D; Heintges, T; Hensel, F; Niederau, C; Niederau, CM; Petry, W; Wenning, M	1
Fazio, V; Scotto, G; Tantimonaco, G	1
Sharara, AI	1
Fiume, L; Verme, G	1
Dienstag, JL	1
Iosue, K	1
Axiotis, CA; Bergasa, NV; Di Bisceglie, AM; Fong, TL; Fried, MW; Hoofnagle, JH; Park, Y; Shindo, M; Swain, MG; Waggoner, JG	1
Andersson, J; Reichard, O; Schvarcz, R; Weiland, O	1
Métreau, JM	1

Reviews

14 review(s) available for ribavirin and Hepatitis, Chronic

Article	Year
Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment. World journal of gastroenterology, 2020, Oct-07, Volume: 26, Issue:37 Topics: Aged; Aged, 80 and over; Animals; Antiviral Agents; Female; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Pregnancy; Ribavirin; Swine	2020
Hepatitis E virus infection. Nature reviews. Disease primers, 2017, Nov-16, Volume: 3 Topics: Animals; Antiviral Agents; Blood Donors; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Ribavirin; Risk Factors; Zoonoses	2017
Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse. Current opinion in virology, 2018, Volume: 32 Topics: Antiviral Agents; Drug Resistance, Multiple, Viral; Genome, Viral; Genotype; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Interferon-alpha; Open Reading Frames; Polymorphism, Single Nucleotide; Ribavirin; Treatment Failure	2018
Chronic hepatitis E infection: risks and controls. Intervirology, 2013, Volume: 56, Issue:4 Topics: Animals; Communicable Disease Control; Foodborne Diseases; Hepatitis E; Hepatitis, Chronic; Humans; Immunocompromised Host; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Zoonoses	2013
Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis. Viruses, 2016, 08-15, Volume: 8, Issue:8 Topics: Hepatitis E; Hepatitis, Chronic; Humans; Interferons; Organ Transplantation; Ribavirin; Transplant Recipients	2016
Chronic viral hepatitis: epidemiology, molecular biology, and antiviral therapy. Frontiers in bioscience (Landmark edition), 2011, 01-01, Volume: 16, Issue:1 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis D, Chronic; Hepatitis Delta Virus; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2011
Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22 Suppl 8 Topics: Antiviral Agents; Fibrosis; Hepatitis B, Chronic; Hepatitis, Chronic; Humans; Immunoglobulins; Interferons; Liver Transplantation; Polyethylene Glycols; Recurrence; Ribavirin; Treatment Outcome	2007
[Factors of response to treatment with interferon-alpha in patients with chronic hepatitis C. Therapeutic perspectives]. Gastroenterologie clinique et biologique, 1995, Volume: 19, Issue:12 Topics: Age Factors; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Hepatitis, Chronic; Humans; Interferon-alpha; Liver; Male; Recurrence; Ribavirin; Sex Factors	1995
[Treatment of hepatitis C]. Pathologie-biologie, 1995, Volume: 43, Issue:8 Topics: Antiviral Agents; Hepacivirus; Hepatitis C; Hepatitis, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Prognosis; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors	1995
[Outcomes research in therapy of chronic hepatitis C]. Der Internist, 1996, Volume: 37, Issue:12 Topics: Combined Modality Therapy; Contraindications; Dose-Response Relationship, Drug; Drug Administration Schedule; Hepatitis C; Hepatitis, Chronic; Humans; Interferons; Liver Function Tests; Ribavirin; Treatment Outcome	1996
Chronic hepatitis C. Southern medical journal, 1997, Volume: 90, Issue:9 Topics: Antiviral Agents; Blood Transfusion; Carcinoma, Hepatocellular; Cryoglobulinemia; Disease Progression; Forecasting; Genotype; Glomerulonephritis, Membranoproliferative; Hepacivirus; Hepatitis C; Hepatitis, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Porphyria Cutanea Tarda; Ribavirin; Risk Factors; Treatment Outcome	1997
Liver targeting of nucleoside analogues coupled to galactosyl terminating macromolecules: a new approach to the treatment of a chronic viral hepatitis. Italian journal of gastroenterology and hepatology, 1997, Volume: 29, Issue:3 Topics: Amino Sugars; Animals; Antiviral Agents; Asialoglycoproteins; DNA; Drug Carriers; Galactose; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Liver; Lysosomes; Polylysine; Ribavirin; Serum Albumin; Vidarabine Phosphate; Virus Replication	1997
Chronic hepatitis C: latest treatment options. The Nurse practitioner, 2002, Volume: 27, Issue:4 Topics: Algorithms; Hepacivirus; Hepatitis C; Hepatitis, Chronic; Humans; Interferons; Quality of Life; Ribavirin; Risk Factors	2002
[Treatment of chronic active B and non A-non B hepatitis]. Gastroenterologie clinique et biologique, 1989, Volume: 13, Issue:2 Pt 3 Topics: Acyclovir; Adrenal Cortex Hormones; Hepatitis B; Hepatitis C; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Interferons; Ribavirin	1989

Trials

4 trial(s) available for ribavirin and Hepatitis, Chronic

Article	Year
Treatment with ribavirin+alpha interferon in HCV chronic active hepatitis non-responders to interferon alone: preliminary results. Journal of chemotherapy (Florence, Italy), 1995, Volume: 7, Issue:1 Topics: Adult; Alanine Transaminase; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Hepatitis, Chronic; Humans; Interferon Type I; Male; Middle Aged; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome	1995
Combined alpha-interferon and ribavirin treatment in chronic hepatitis C: a pilot study. Scandinavian journal of infectious diseases, 1995, Volume: 27, Issue:4 Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Base Sequence; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Hepatitis, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Molecular Sequence Data; Pilot Projects; Polymerase Chain Reaction; Ribavirin; RNA, Viral; Treatment Outcome	1995
Pilot study of a short course of ribavirin and alpha interferon in the treatment of chronic active hepatitis C not responding to alpha-interferon alone. The Italian journal of gastroenterology, 1996, Volume: 28, Issue:9 Topics: Adult; Alanine Transaminase; Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Hepatitis, Chronic; Humans; Interferon Type I; Male; Pilot Projects; Polymerase Chain Reaction; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome	1996
Ribavirin treatment for chronic hepatitis C. Lancet (London, England), 1991, May-04, Volume: 337, Issue:8749 Topics: Administration, Oral; Adult; Alanine Transaminase; Drug Administration Schedule; Drug Evaluation; Female; Hepatitis C; Hepatitis, Chronic; Humans; Male; Middle Aged; Pilot Projects; Ribavirin	1991

Other Studies

43 other study(ies) available for ribavirin and Hepatitis, Chronic

Article	Year
Unmet Needs for the Treatment of Chronic Hepatitis E Virus Infection in Immunocompromised Patients. Viruses, 2022, 09-25, Volume: 14, Issue:10 Topics: Animals; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Immunocompromised Host; Rats; Ribavirin	2022
[Intrahepatic and extrahepatic clinical manifestations and treatment progress for hepatitis type E]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023, May-20, Volume: 31, Issue:5 Topics: Antiviral Agents; Hepatitis E virus; Hepatitis, Chronic; Humans; Liver Diseases; Liver Failure; Ribavirin	2023
Chronic hepatitis E infection in an immunosuppressed, solid organ transplant patient. Internal medicine journal, 2019, Volume: 49, Issue:10 Topics: Fatal Outcome; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Organ Transplantation; Ribavirin	2019
Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for Difficult-To-Treat Chronic Hepatitis E. International journal of environmental research and public health, 2020, 01-03, Volume: 17, Issue:1 Topics: Adult; Aged; Antiviral Agents; Drug Resistance; Hepatitis, Chronic; Humans; Male; Middle Aged; Ribavirin; Risk Assessment; Risk Factors; Rituximab; Treatment Outcome; Young Adult	2020
Ribavirin long-term treatment for chronic hepatitis E virus infection in a liver transplant recipient. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2020, Volume: 52, Issue:8 Topics: Aged; Antiviral Agents; Dose-Response Relationship, Drug; Hepatitis E; Hepatitis, Chronic; Humans; Immunosuppressive Agents; Liver Transplantation; Off-Label Use; Ribavirin; Transplant Recipients	2020
Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients. BMC infectious diseases, 2020, Jul-16, Volume: 20, Issue:1 Topics: Drug Resistance, Viral; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Interferon-alpha; Kidney Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Remission Induction; Ribavirin; Sustained Virologic Response; Transplant Recipients; Treatment Outcome	2020
Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin. AIDS (London, England), 2017, 06-01, Volume: 31, Issue:9 Topics: Alanine Transaminase; Antiviral Agents; Coinfection; Hepatitis B; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; HIV Infections; Humans; Male; Middle Aged; Ribavirin; Sofosbuvir; Treatment Failure; Viral Load	2017
Chronic hepatitis in the transplant patient. British journal of hospital medicine (London, England : 2005), 2017, Jul-02, Volume: 78, Issue:7 Topics: Aged; Alanine Transaminase; Antiviral Agents; Graft Rejection; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunocompromised Host; Immunoglobulin M; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Polycystic Kidney Diseases; Polymerase Chain Reaction; Ribavirin; RNA, Viral; Tacrolimus; Viral Load	2017
Chronic hepatitis E virus infection in a cirrhotic patient: A case report. Medicine, 2017, Volume: 96, Issue:39 Topics: Antiviral Agents; Enzyme-Linked Immunospot Assay; Hepatitis E; Hepatitis, Chronic; Humans; Interferon-gamma; Liver Cirrhosis; Male; Middle Aged; Ribavirin	2017
Genotype 4 hepatitis E virus is a cause of chronic hepatitis in renal transplant recipients in Hong Kong. Journal of viral hepatitis, 2018, Volume: 25, Issue:2 Topics: Aged; Antibodies, Viral; Antiviral Agents; Genotype; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Hong Kong; Humans; Immunocompromised Host; Immunoglobulin M; Kidney Transplantation; Male; Middle Aged; Mutation; Retrospective Studies; Ribavirin; Transplant Recipients; Viral Load	2018
Treating chronic hepatitis E: when is enough enough? BMJ case reports, 2018, Feb-01, Volume: 2018 Topics: Adult; Alanine Transaminase; Antiviral Agents; Feces; Hepatitis E; Hepatitis, Chronic; Humans; Immunocompromised Host; Kidney Transplantation; Male; Opportunistic Infections; Ribavirin; Treatment Outcome; Viral Load; Virus Shedding	2018
Chronic Hepatitis E in a Renal Transplant Recipient: The First Report of Genotype 4 Hepatitis E Virus Caused Chronic Infection in Organ Recipient. Gastroenterology, 2018, Volume: 154, Issue:4 Topics: Adult; Antiviral Agents; Genotype; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Phenotype; Ribavirin; Treatment Outcome	2018
Should 12- or 24-week post-ribavirin follow-up be considered to define sustained virological response in transplant patients treated for chronic hepatitis E virus infection? Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:3 Topics: Antiviral Agents; Drug Administration Schedule; Follow-Up Studies; Genotype; Hepatitis E virus; Hepatitis, Chronic; Humans; Organ Transplantation; Ribavirin; Sustained Virologic Response; Transplant Recipients	2019
The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study. Journal of hepatology, 2019, Volume: 71, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Antiviral Agents; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Ribavirin; Rituximab; RNA, Viral; Survival Rate; Young Adult	2019
Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin. Viruses, 2019, 07-09, Volume: 11, Issue:7 Topics: Adult; Aged; Antiviral Agents; Female; Genotype; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunocompromised Host; Kinetics; Male; Middle Aged; Organ Transplantation; Plasma; Ribavirin; RNA, Viral; Sustained Virologic Response; Transplant Recipients; Treatment Failure; Virus Replication	2019
Chronic hepatitis E after kidney transplantation with an antibody response suggestive of reinfection: a case report. BMC infectious diseases, 2019, Jul-30, Volume: 19, Issue:1 Topics: Antibody Formation; Antiviral Agents; Enzyme-Linked Immunosorbent Assay; Hepatitis Antibodies; Hepatitis E; Hepatitis, Chronic; Humans; Immunocompromised Host; Immunoglobulin G; Kidney Transplantation; Male; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral	2019
Chronic hepatitis E resolution in a human immunodeficiency virus (HIV)-infected patient treated with ribavirin. International journal of antimicrobial agents, 2013, Volume: 41, Issue:6 Topics: Alanine Transaminase; Antiviral Agents; CD4 Lymphocyte Count; Hepatitis E; Hepatitis, Chronic; HIV Infections; Humans; Male; Middle Aged; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load	2013
Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response. The Journal of infection, 2013, Volume: 67, Issue:1 Topics: Adult; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Female; Genotype; Hepatitis, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Spain; Treatment Outcome	2013
Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:3 Topics: Antiviral Agents; Hepatitis E; Hepatitis, Chronic; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Ribavirin; Treatment Outcome	2013
Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus. Gastroenterology, 2014, Volume: 146, Issue:7 Topics: Antiviral Agents; Calcineurin; Calcineurin Inhibitors; Cell Line, Tumor; Cyclophilin A; Cyclophilins; Cyclosporine; Dose-Response Relationship, Drug; HEK293 Cells; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunosuppressive Agents; Mycophenolic Acid; Ribavirin; RNA Interference; RNA, Viral; Time Factors; Transfection; Virus Replication	2014
Successful Treatment of Chronic Hepatitis E After an Orthotopic Liver Transplant With Ribavirin Monotherapy. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2015, Volume: 13, Issue:3 Topics: Antiviral Agents; Biopsy; Hepatitis E; Hepatitis, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Opportunistic Infections; Ribavirin; Time Factors; Treatment Outcome; Viral Load	2015
A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients. Gastroenterology, 2014, Volume: 147, Issue:5 Topics: Antiviral Agents; DNA-Directed RNA Polymerases; Dose-Response Relationship, Drug; Drug Resistance, Viral; Female; Genotype; Hep G2 Cells; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Male; Mutagenesis, Site-Directed; Mutation; Organ Transplantation; Phenotype; Ribavirin; Time Factors; Transfection; Treatment Failure; Virus Replication	2014
Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting. Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:4 Topics: Adolescent; Adult; Aged; Antiviral Agents; Female; Hepatitis E; Hepatitis, Chronic; Humans; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Ribavirin; Treatment Outcome; Young Adult	2015
Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies. Emerging infectious diseases, 2015, Volume: 21, Issue:8 Topics: Antiviral Agents; Hematologic Neoplasms; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Ribavirin	2015
First Case Genotype 4 Hepatitis E Infection After a Liver Transplant. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2017, Volume: 15, Issue:2 Topics: Antiviral Agents; Biopsy; Fatal Outcome; Female; Genotype; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Liver Function Tests; Liver Transplantation; Middle Aged; Phenotype; Predictive Value of Tests; Ribavirin; RNA, Viral; Treatment Outcome	2017
[Chronic hepatitis caused by hepatitis E virus and treated with ribavirin]. Gastroenterologia y hepatologia, 2016, Volume: 39, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Ascites; Enterobacteriaceae Infections; Female; Hafnia alvei; Hematopoietic Stem Cell Transplantation; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Middle Aged; Ribavirin; Rituximab; Transplantation, Autologous	2016
Ribavirin for Chronic Hepatitis E in Liver-Transplant Setting: A Safe and Highly Effective Therapy. Journal of clinical gastroenterology, 2016, Volume: 50, Issue:7 Topics: Adult; Amyloid Neuropathies, Familial; Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis E; Hepatitis, Chronic; Hepatolenticular Degeneration; Humans; Interferon-alpha; Liver Transplantation; Ribavirin; Treatment Outcome	2016
Treatment of chronic hepatitis E with ribavirin: lessons from deep sequencing. Gut, 2016, Volume: 65, Issue:10 Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Hepatitis E; Hepatitis, Chronic; High-Throughput Nucleotide Sequencing; Humans; Interferon-alpha; Recombinant Proteins; Ribavirin; Treatment Outcome	2016
Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection. Journal of hepatology, 2017, Volume: 66, Issue:1 Topics: Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Male; Middle Aged; Ribavirin; Sofosbuvir	2017
Exacerbation of hepatitis E virus infection during anti-TNFα treatment. Joint bone spine, 2017, Volume: 84, Issue:2 Topics: Aged; Antirheumatic Agents; Antiviral Agents; Arthritis, Psoriatic; Etanercept; Hepatitis E; Hepatitis, Chronic; Humans; Immunocompromised Host; Male; Ribavirin; Tumor Necrosis Factor-alpha	2017
Chronic hepatitis E in a patient with rheumatoid arthritis treated with adalimumab and methotrexate. Rheumatology (Oxford, England), 2017, Mar-01, Volume: 56, Issue:3 Topics: Adalimumab; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Hepatitis E; Hepatitis, Chronic; Humans; Immunocompromised Host; Male; Methotrexate; Middle Aged; Ribavirin	2017
Clinical approach to the patient with chronic hepatitis C infection and normal aminotransferases. Annals of hepatology, 2010, Volume: 9 Suppl Topics: Alanine Transaminase; Antiviral Agents; Biomarkers; Clinical Enzyme Tests; Drug Therapy, Combination; Hepatitis, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Cirrhosis; Patient Selection; Polyethylene Glycols; Practice Guidelines as Topic; Predictive Value of Tests; Recombinant Proteins; Reference Values; Ribavirin; Risk Assessment; Risk Factors; Severity of Illness Index; Treatment Outcome	2010
Interferon-alpha therapy in patients with hepatitis C virus infection increases plasma phenylalanine and the phenylalanine to tyrosine ratio. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2012, Volume: 32, Issue:5 Topics: Adult; Biosynthetic Pathways; Chromatography, High Pressure Liquid; Female; Hepacivirus; Hepatitis, Chronic; Humans; Immunotherapy; Interferon-alpha; Male; Middle Aged; Mood Disorders; Phenylalanine; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Tyrosine; Viral Load	2012
Chronic hepatitis E after solid organ transplantation. The Netherlands journal of medicine, 2012, Volume: 70, Issue:6 Topics: Animals; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunocompromised Host; Ribavirin; RNA, Viral	2012
[Hepatitis C. Chronic hepatitis. Outcome and treatment]. Anales de pediatria (Barcelona, Spain : 2003), 2003, Volume: 58, Issue:5 Topics: Adolescent; Antiviral Agents; Biopsy; Child; Drug Administration Schedule; Hepatitis C; Hepatitis, Chronic; Humans; Interferon-alpha; Liver; Prognosis; Ribavirin; Severity of Illness Index; Treatment Outcome	2003
Determination of glycated hemoglobin in patients with advanced liver disease. World journal of gastroenterology, 2004, Aug-01, Volume: 10, Issue:15 Topics: Antiviral Agents; Fructosamine; Glycated Hemoglobin; Hepatitis C, Chronic; Hepatitis, Chronic; Humans; Liver Cirrhosis; Ribavirin	2004
[Therapeutic challenges in viral hepatitis patients]. Deutsche medizinische Wochenschrift (1946), 2005, Dec-16, Volume: 130 Suppl 5 Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis, Chronic; Humans; Interferons; Ribavirin	2005
[Protocol for the treatment of chronic viral hepatitis]. Orvosi hetilap, 2006, Dec-24, Volume: 147, Issue:51 Topics: Algorithms; Antiviral Agents; Hepatitis C, Chronic; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2006
Clinical-epidemiological features, diagnostics, treatment of chronic viral hepatitises, combined with opisthorchosis in inhabitants of Siberia and the Northern regions of Russia. Alaska medicine, 2007, Volume: 49, Issue:2 Suppl Topics: Adult; Aged; Antiviral Agents; Female; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Interferons; Male; Middle Aged; Opisthorchiasis; Prevalence; Ribavirin; Russia; Siberia; Syndrome; Treatment Outcome	2007
Depression in chronic hepatitis: the virus, the drug, or the ethnic background? Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:4 Topics: Antiviral Agents; Depressive Disorder; Female; Follow-Up Studies; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Chronic; Humans; Interferons; Liver Function Tests; Male; Ribavirin; Risk Assessment; Severity of Illness Index	2008
Ribavirin treatment for chronic hepatitis D: a pilot study. Liver, 1994, Volume: 14, Issue:3 Topics: Adult; Follow-Up Studies; Hepatitis D; Hepatitis, Chronic; Humans; Male; Pilot Projects; Ribavirin; Time Factors	1994
New antiviral agents for viral hepatitis: our cup runneth over but is only half full. Gastroenterology, 1999, Volume: 117, Issue:3 Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Interferons; Lamivudine; Ribavirin	1999
A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology (Baltimore, Md.), 1992, Volume: 16, Issue:3 Topics: Adult; Aged; Alanine Transaminase; Biomarkers; Drug Administration Schedule; Female; Hepatitis C; Hepatitis, Chronic; Humans; Male; Middle Aged; Pilot Projects; Ribavirin; RNA, Viral	1992